US Patent Issued to SHUJING BIOPHARMA, JIANGSU NHWA PHARMACEUTICAL on Sept. 1 for "Heterocyclic substituted fused Gamma-carboline derivative, preparation method therefor, intermediate thereof and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,044, issued on Sept. 1, was assigned to SHUJING BIOPHARMA Co. LTD (Shanghai) and JIANGSU NHWA PHARMACEUTICAL Co. LTD (Xuzhou, China).

"Heterocyclic substituted fused Gamma-carboline derivative, preparation method therefor, intermediate thereof and use thereof" was invented by Zehong Wan (Shanghai), Jiaquan Feng (Shanghai), Yongqi Wu (Shanghai), Jun Qin (Shanghai), Bingcheng Zhou (Shanghai), Zhijing Hu (Shanghai), Xinjian Jiang (Shanghai) and Zijin Feng (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a heterocyclic substituted fused Gamma-carboline derivative, a preparation method therefor, an intermediate th...